Compile Data Set for Download or QSAR
Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 50020939
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658474(US20240083900, Example 190 | 1-((1R,5R,6S)-6-methy...)
Affinity DataKd:  0.310nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658420(US20240083900, Example 29)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of BTK (unknown origin) using fluorescein labeled polyGAT peptide substrate incubated for 30 mins in presence of ATP by time-resolved fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658420(US20240083900, Example 29)
Affinity DataKd:  0.600nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataKd:  0.630nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of PLCgamma2 phosphorylation in anti-IgM activated human Ramos cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM50557487(Tolebrutinib)
Affinity DataKd:  1.40nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of BTK in human TMD8 cells assessed as reduction in CD36 expressionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658420(US20240083900, Example 29)
Affinity DataIC50: 2.30nMAssay Description:Inhibition of BTK in human Ramos cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658329(US20240083900, Example 4)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of BTK (unknown origin) using fluorescein labeled polyGAT peptide substrate incubated for 30 mins in presence of ATP by time-resolved fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataIC50: 4.20nMAssay Description:Inhibition of BTK in human TMD8 cells assessed as reduction in CD19 expressionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658330(US20240083900, Example 11)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of BTK (unknown origin) using fluorescein labeled polyGAT peptide substrate incubated for 30 mins in presence of ATP by time-resolved fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM291522(US9580449, Example A39 | 1-(4-(((6-amino-5-(4-phen...)
Affinity DataKd:  4.60nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetTyrosine-protein kinase BTK(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658257(US20240083900, Example 2)
Affinity DataIC50: 63nMAssay Description:Inhibition of BTK (unknown origin) using fluorescein labeled polyGAT peptide substrate incubated for 30 mins in presence of ATP by time-resolved fluo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CaV1.2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetSodium channel protein type 5 subunit alpha(Human)
Biogen Research and Development

Curated by ChEMBL
LigandPNGBDBM658433(US20240083900, Example 79)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of NaV1.5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed